Skip to main content

Cencora Inc. Value Stock - Dividend - Research Selection

Amerisourcebergen

ISIN: US03073E1055 , WKN: 766149

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company\'s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Cencora Earnings Preview: What to Expect

2026-07-17
Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth.

2 DiviDog Buys By Barron's Mid-Year Round Table Pros

2026-07-17
Read here for an update on Barron’s 2026 dividend “dogcatcher” picks—safer high-yield stocks, projected gains to 2027, and free-cash-flow red flags.

Artisan Mid Cap Fund Q2 2026 Performance Review

2026-07-15
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Growth Index. Read more here.

Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review

2026-07-14
Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Read more here.

Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers

2026-07-13
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Cencora (NYSE:COR) and its peers.

Should You Retain CAH Stock After Removal From Several Russell Indices?

2026-07-09
CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.

McKesson Stock Is Shrinking, and That's The Point for Owners

2026-07-09
While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.

3 Market-Beating Stocks for Long-Term Investors

2026-07-09
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

McKesson Stock Is Shrinking, And That's The Point

2026-07-08
While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.

McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big Catch

2026-07-08
McKesson is a stable portfolio holding with regular moderate growth amid a challenging, overvalued market environment. Read more on MCK stock here.